Together, these results demonstrate a specific role for BCL2 in the proliferation of human BCR-ABL-positive ALL cells and suggest that the miR-17∼92 cluster suppresses BCL2 in BCR-ABL-positive cells. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.